tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

AVBP Stock Latest News

Company AnnouncementsArriVent BioPharma Reports 2024 Financial Results and Progress
2d ago
AVBP
PremiumRatings
Buy Rating for ArriVent BioPharma: Promising Clinical Developments and Strategic Progress in NSCLC Treatment
2d ago
AVBP
ArriVent Biopharma sees cash runway into 2026
PremiumThe Fly
ArriVent Biopharma sees cash runway into 2026
3d ago
AVBP
ArriVent Biopharma reports FY24 EPS ($2.56), consensus ($2.69)
PremiumThe Fly
ArriVent Biopharma reports FY24 EPS ($2.56), consensus ($2.69)
3d ago
AVBP
ArriVent Biopharma announces upcoming milestones
PremiumThe Fly
ArriVent Biopharma announces upcoming milestones
3d ago
AVBP
ArriVent Biopharma files automatic mixed securities shelf
PremiumThe FlyArriVent Biopharma files automatic mixed securities shelf
1M ago
AVBP
ArriVent Biopharma price target raised to $39 from $36 at H.C. Wainwright
Premium
The Fly
ArriVent Biopharma price target raised to $39 from $36 at H.C. Wainwright
1M ago
AVBP
Premium
Company Announcements
ArriVent BioPharma Expands Oncology Pipeline with New License
1M ago
8K
AVBP
PremiumCompany Announcements
ArriVent BioPharma Advances Cancer Therapeutics Pipeline
4M ago
AVBP
ArriVent Biopharma reports Q3 EPS (61c), consensus ($1.07)
PremiumThe Fly
ArriVent Biopharma reports Q3 EPS (61c), consensus ($1.07)
4M ago
AVBP
ArriVent Biopharma price target raised to $36 from $30 at Citi
PremiumThe Fly
ArriVent Biopharma price target raised to $36 from $30 at Citi
6M ago
AVBP
ArriVent Biopharma price target raised to $39 from $35 at Oppenheimer
PremiumThe Fly
ArriVent Biopharma price target raised to $39 from $35 at Oppenheimer
6M ago
AVBP
ArriVent Biopharma price target raised to $36 from $30 at H.C. Wainwright
PremiumThe FlyArriVent Biopharma price target raised to $36 from $30 at H.C. Wainwright
6M ago
AVBP
ArriVent announces PoC global Phase 1b interim data for firmonertinib
Premium
The Fly
ArriVent announces PoC global Phase 1b interim data for firmonertinib
6M ago
AVBP
Corbus Pharmaceuticals appoints Kung to board of directors
Premium
The Fly
Corbus Pharmaceuticals appoints Kung to board of directors
7M ago
AVBP
CRBP
ArriVent Biopharma price target raised to $30 from $25 at H.C. Wainwright
PremiumThe Fly
ArriVent Biopharma price target raised to $30 from $25 at H.C. Wainwright
7M ago
AVBP
ArriVent Biopharma reports Q2 EPS (65c), consensus (64c)
PremiumThe Fly
ArriVent Biopharma reports Q2 EPS (65c), consensus (64c)
7M ago
AVBP
ArriVent Biopharma initiated with an Outperform at Oppenheimer
PremiumThe Fly
ArriVent Biopharma initiated with an Outperform at Oppenheimer
8M ago
AVBP
PremiumCompany Announcements
ArriVent BioPharma’s Strategic Alliance for Cancer Drug Development
9M ago
8K
AVBP
ArriVent Biopharma announces multi-target ADC collaboration with Alphamab
PremiumThe FlyArriVent Biopharma announces multi-target ADC collaboration with Alphamab
9M ago
AVBP
Premium
Company Announcements
ArriVent BioPharma Welcomes Dr. Hohneker to Board
10M ago
8K
AVBP
ArriVent Biopharma reports Q1 EPS (70c), consensus ($1.10)
Premium
The Fly
ArriVent Biopharma reports Q1 EPS (70c), consensus ($1.10)
10M ago
AVBP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >